Safety and efficacy of edoxaban in patients undergoing hip fracture surgery

Thrombosis Research

Volumn 133, Issue 6, 2014, Pages 1016-1022

  Fuji, Takeshi ^a   Fujita, Satoru ^b   Kawai, Yohko ^c   Nakamura, Mashio ^d   Kimura, Tetsuya ^e   Kiuchi, Yuichi ^e   Abe, Kenji ^e   Tachibana, Shintaro ^f  

^a OSAKA KOSEI NENKIN HOSPITAL   (Japan)

^b Takarazuka Daiichi Hospital   (Japan)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^d MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e DAIICHI SANKYO CO   (Japan)

^f Mishuku Hospital   (Japan)

Author keywords

Edoxaban; Enoxaparin; Factor Xa; Hip fracture surgery; Venous thromboembolism

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; EDOXABAN; ENOXAPARIN; GAMMA GLUTAMYLTRANSFERASE; BLOOD CLOTTING FACTOR 10A INHIBITOR; PYRIDINE DERIVATIVE; THIAZOLE DERIVATIVE;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTICOAGULANT THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DECUBITUS; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMATURIA; HIP FRACTURE; HIP SURGERY; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOEMBOLISM; THROMBOSIS PREVENTION; URINARY TRACT INFECTION; BLOOD LOSS, SURGICAL; CLINICAL TRIAL; DRUG ADMINISTRATION; HIP FRACTURES; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; BLOOD LOSS, SURGICAL; DRUG ADMINISTRATION SCHEDULE; ENOXAPARIN; FACTOR XA INHIBITORS; FEMALE; HIP FRACTURES; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; PYRIDINES; THIAZOLES; THROMBOEMBOLISM;

EID: 84900467866     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.03.009     Document Type: Article

References (21)

1. Y. Falck-Ytter, C.W. Francis, N.A. Johanson, C. Curley, O.E. Dahl, and S. Schulman et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e278S e325S
2. JCS Joint Working Group Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009) Circ J 75 2011 1258 1281
3. W.H. Geerts, G.F. Pineo, J.A. Heit, D. Berggvist, M.R. Lassen, and C.W. Colwell et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 338S 400S
4. M. Nakamura, H. Fujioka, N. Yamada, M. Sakuma, O. Okada, and N. Nakanishi et al. Clinical characteristics of acute pulmonary thromboembolism in Japan: results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research Clin Cardiol 24 2001 132 138
5. M. Ota, M. Nakamura, N. Yamada, T. Yazu, K. Ishikura, and N. Hiraoka et al. Prognostic significance of early diagnosis in acute pulmonary thromboembolism with circulatory failure Heart Vessels 17 2002 7 11
6. T. Fuji, T. Ochi, S. Niwa, and S. Fujita Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin J Orthop Sci 13 2008 442 451
7. T. Fuji, S. Fujita, and T. Ochi Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients Int Orthop 32 2008 443 451
8. T. Wilke, J. Moock, S. Muller, M. Pfannkuche, and A. Kurth Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery Clin Orthop Relat Res 468 2010 2437 2453
9. G. Spahn Compliance with self-administration of heparin injections in outpatients Eur J Trauma 28 2002 104 109
10. N. Matsushima, F. Lee, T. Sato, D. Weiss, and J. Mendell Bioavailability and safety of the factor Xa inhibitor edoxaban and the effects of quinidine in healthy subjects Clin Pharm Drug Dev 2 2013 358-6
11. K. Ogata, J. Mendell-Harary, M. Tachibana, H. Masumoto, T. Oguma, and M. Kojima et al. Clinical safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers J Clin Pharmacol 50 2010 743 753
12. T. Fuji, S. Fujita, S. Tachibana, and Y. Kawai A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty J Thromb Haemost 8 2010 2458 2468
13. T. Fuji, C.-J. Wang, S. Fujita, S. Tachibana, and Y. Kawai Edoxaban in patients undergoing total hip arthroplasty: a phase IIb dose-finding study ASH Annu Meet Abstr 114 2009 2098
14. G. Raskob, A.T. Cohen, B.I. Eriksson, D. Puskas, M. Shi, and T. Bocanegra et al. Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study Thromb Haemost 104 2010 642 649
15. Clexane® for Subcutaneous Injection Kit 2000 IU [Package Insert (Ver. 5), in Japanese] 2010 Sanofi-Aventis K.K. Tokyo, Japan
16. T. Fuji, C.J. Wang, S. Fujita, S. Tachibana, Y. Kawai, and Y. Koretsune et al. Edoxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial Pathophysiol Haemost Thromb 37 2010 A20 [Abstract OC297]
17. T. Fuji, S. Fujita, S. Tachibana, Y. Kawai, Y. Koretsune, and T. Yamashita et al. Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V trial Blood 116 2010 (Abstract 3320)
18. T. Fuji, S. Fujita, S. Tachibana, and Y. Kawai Edoxaban versus enoxaparin for the prevention of venous thromboembolism: pooled analysis of venous thromboembolism and bleeding from STARS E-3 and STARS J-V Blood 118 2011 208
19. D.E. Salazar, J. Mendell, H. Kastrissios, M. Green, T. Carrothers, and S. Song et al. Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation Thromb Haemost 107 2012 925 936
20. M.K. Carlson, P.P. Gleason, and S. Sen Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity Pharmacotherapy 21 2001 108 113
21. Lixiana [package insert] 2011 Daiichi Sankyo Co. Ltd. Tokyo, Japan